Focused Ultrasound Foundation to launch research initiative

Friday, September 6, 2013 02:45 PM

The Focused Ultrasound Foundation and Royal Philips have entered into a public-private collaboration with The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust. The partnership will create a focal point for ultrasound therapy research at ICR and The Royal Marsden in London under the international Focused Ultrasound Foundation Centers of Excellence Program.

The initiative will create a state-of-the-art resource for clinicians and scientists working on high intensity focused ultrasound therapy, developing clinical evidence in oncology and establishing best practices, treatment standards and protocols. Focused ultrasound concentrates ultrasound energy with high precision on target tissue in the body to thermally destroy tissue. The technology is coupled with image guidance to identify, target and track the treatment in real time. The initiative will launch this autumn with a clinical trial to evaluate treatment of bone metastases in cancer patients.

"High intensity focused ultrasound therapy has tremendous potential in oncology and many other key clinical areas," said Gail ter Haar, DSc., coordinator of the initiative. "To achieve this, we need to collaborate in new ways, establish standards for consistent delivery of treatment and train those who will deliver that care.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs